Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1-guanidino-4-(n-phenylmethanesulfonyl-l-leucyl-l-prolylamino)butane
- Development stage
- Unknown
- Modality
- Peptides, Small Molecules
01
Overview
1-Guanidino-4-(N-phenylmethanesulfonyl-L-leucyl-L-prolylamino)butane is a synthetic small molecule dipeptide derivative, structurally characterized by a guanidino group and a sulfonamide linkage to L-leucine and L-proline residues. It has been studied as an experimental compound but is not approved for clinical use in any country. There are no known indications or approved uses, and it does not appear to have reached clinical development beyond preclinical or early research stages. Its mechanism of action, biological targets, and therapeutic potential remain uncharacterized in the public domain[1][2][5].
- Other names
- (2S)-N-{4-[(diaminomethylidene)amino]butyl}-1-[(2S)-4-methyl-2-(phenylmethane)sulfonamidopentanoyl]pyrrolidine-2-carboxamideN-(benzylsulfonyl)-L-leucyl-N-{4-[amino(imino)methyl]amino}butyl-L-prolinamide
Beyond the preview
Go deeper on 1-guanidino-4-(n-phenylmethanesulfonyl-l-leucyl-l-prolylamino)butane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1-guanidino-4-(n-phenylmethanesulfonyl-l-leucyl-l-prolylamino)butane.